Zhejiang Gongdong Medical Technology's deputy general manager Lai Shangxiao's relatives engaged in insider trading of the company's stock.

Zhejiang Gongdong Medical Technology (605369.SH) has released an announcement stating that the company recently received a statement and apology letter from its Deputy General Manager, Mr. Lai Shangxiao, regarding his son, Mr. Lai Juncheng, engaging in short-term trading of the company's stock from April 24, 2024 to June 20, 2024 using the centralized bidding trading method. Upon investigation, it was found that Mr. Lai Juncheng purchased a total of 200 shares of the company's stock during the aforementioned period, with a total transaction amount of 8,620.00 yuan, and sold a total of 200 shares of the company's stock with a total transaction amount of 9,516.00 yuan. According to regulations, the profits from this transaction should belong to the company. As of the date of this announcement, Mr. Lai Juncheng has fully handed over the profit of 896.00 yuan from the short-term trading to the company.